Global Medical Cannabis Market Research Report 2020

Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
The various economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market.

The global Medical Cannabis market is valued at 12870 million US$ in 2020 is expected to reach 30520 million US$ by the end of 2026, growing at a CAGR of 13.0% during 2021-2026.
This report focuses on Medical Cannabis volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Cannabis market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Medical Cannabis market is segmented into
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)

Segment by Application
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others

Global Medical Cannabis Market: Regional Analysis
The Medical Cannabis market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Medical Cannabis market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Medical Cannabis Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Medical Cannabis market include:
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc